GlassScriptPhysician profile
Salahuddin Mohamed
NPI 1518609205
$1,841.45
in general payments reported to CMS, 2019-2025
17 companies · $610 in 2025
The $610 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $249 · 2023: $515 · 2024: $468 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Travel and Lodging: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.43 |
| Travel and Lodging | $476.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $476.96 | 2025 | Clottriever Bold Catheter |
| Astrazeneca Pharmaceuticals LP | $307.57 | 2022-2024 | Airsupra, Farxiga, Breztri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $264.49 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $155.61 | 2022 | |
| Medtronic, INC. | $148.78 | 2023 | Micra |
| Kestra Medical Technology Services, INC. | $85.27 | 2023 | Assure Wcd |
| Glaxosmithkline, LLC. | $78.99 | 2025 | Arexvy |
| Novartis Pharmaceuticals Corporation | $65.73 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $55.27 | 2022-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $45.20 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $28.68 | 2025 | Wavewriter Alpha Prime 16 |
| Cvrx, INC. | $28.65 | 2024 | Barostim Neo System |
| Vifor Pharma, INC. | $25.27 | 2025 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $23.41 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.60 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.22 | 2024 | Rexulti |
| Baxter Healthcare | $12.75 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salahuddin Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.